2fle: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2fle.png|left|200px]] | [[Image:2fle.png|left|200px]] | ||
{{STRUCTURE_2fle| PDB=2fle | SCENE= }} | {{STRUCTURE_2fle| PDB=2fle | SCENE= }} | ||
===Structural analysis of asymmetric inhibitor bound to the HIV-1 Protease V82A mutant=== | ===Structural analysis of asymmetric inhibitor bound to the HIV-1 Protease V82A mutant=== | ||
{{ABSTRACT_PUBMED_18215016}} | {{ABSTRACT_PUBMED_18215016}} | ||
==About this Structure== | ==About this Structure== | ||
[[2fle]] is a 2 chain structure of [[Virus protease]] with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FLE OCA]. | |||
==See Also== | |||
*[[Virus protease|Virus protease]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:018215016</ref><references group="xtra"/> | ||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
[[Category: Clemente, J C.]] | [[Category: Clemente, J C.]] | ||
| Line 34: | Line 25: | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Resistance]] | [[Category: Resistance]] | ||
Revision as of 00:40, 27 July 2012
Structural analysis of asymmetric inhibitor bound to the HIV-1 Protease V82A mutantStructural analysis of asymmetric inhibitor bound to the HIV-1 Protease V82A mutant
Template:ABSTRACT PUBMED 18215016
About this StructureAbout this Structure
2fle is a 2 chain structure of Virus protease with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Clemente JC, Robbins A, Grana P, Paleo MR, Correa JF, Villaverde MC, Sardina FJ, Govindasamy L, Agbandje-McKenna M, McKenna R, Dunn BM, Sussman F. Design, synthesis, evaluation, and crystallographic-based structural studies of HIV-1 protease inhibitors with reduced response to the V82A mutation. J Med Chem. 2008 Feb 28;51(4):852-60. Epub 2008 Jan 24. PMID:18215016 doi:10.1021/jm701170f